Navigation Links
FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
Date:12/20/2011

atients with renal disease, chlorthalidone may precipitate azotemia. Consider withholding or discontinuing EDARBI or EDARBYCLOR if progressive renal impairment becomes evident.

EDARBYCLOR attenuates chlorthalidone-associated hypokalemia. Hypokalemia is a dose-dependent adverse reaction that may develop with chlorthalidone. Coadministration of digitalis may exacerbate the adverse effects of hypokalemia.

Hyperuricemia (chlorthalidone) may occur or frank gout may be precipitated in certain patients receiving chlorthalidone or other thiazide diuretics.

The most common adverse reaction that occurred more frequently with EDARBI than placebo in adults was diarrhea (2 percent versus 0.5 percent). The adverse reactions that occurred at an incidence of greater than or equal to 2 percent of EDARBYCLOR-treated patients, and greater than azilsartan medoxomil or chlorthalidone, were dizziness and fatigue. Elevations of creatinine (2 percent) were typically transient, or nonprogressive and reversible, and associated with large blood pressure reductions.

Patients receiving EDARBI or EDARBYCLOR and nonsteroidal anti-inflammatory drugs (NSAIDs) who are also elderly, volume-depleted (including those on diuretics), or who have compromised renal function due to potential reversible deterioration of renal function should have their renal function monitored periodically. NSAIDs increase risk of renal dysfunction and interfere with antihypertensive effect. Renal clearance of lithium is reduced by diuretics, such as chlorthalidone, increasing the risk of lithium toxicity.

For further information:

Please click here for complete EDARBI Prescribing Information or here'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure
2. FDA Approves Hologics Cervista High Throughput Automation System for Cervical Cancer Screening
3. FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor
4. FDA Approves First Insomnia Drug for Middle-of-the-Night Waking Followed By Difficulty Returning to Sleep
5. FDA Approves Eylea for Eye Disorder in Older People
6. FDA Approves First Supplemental Test for Chagas Disease
7. FDA Approves Erwinaze to Treat a Form of Leukemia
8. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
9. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
10. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
11. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 GenomeDx Biosciences today ... the American Society for Radiation Oncology (ASTRO) Annual ... Cancer Classifier, a genomic test capable of predicting ... and improve patient outcomes for prostate cancer patients ... a recently published study that demonstrates how Decipher ...
(Date:9/15/2014)... -- Patients in today,s changing health care landscape are receiving ... setting versus a hospital. In an effort to stay ... continue to receive high quality medical care; Kaiser Permanente ... medicine residency program. The program,s progressive curriculum will prepare ... even virtual settings. "We are excited ...
(Date:9/15/2014)... 15, 2014 /PRNewswire-iReach/ -- On September 8, 2014, ... Carolina, submitted a Citizen Petition to Dr. ... to add another Black Box Warning to Levaquin, ... asks for a Black Box Warning for the ... suicidal thoughts or acts, loss of consciousness, delirium, ...
Breaking Medicine Technology:Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3
... Calif. , May 6 Questcor Pharmaceuticals, Inc ... trading of Questcor,s common stock pending news. The Peripheral and Central ... Administration (FDA) meets today to review and discuss the Company,s supplemental ... injection) for the treatment of infantile spasms. , ...
... May 5 ViaCyte, Inc., a preclinical stage stem cell engineering company focused ... , , ... Patent 7,695,963, entitled "Methods for Increasing Definitive Endoderm Production".  Methods described in this patent ... it. , , , ...
Cached Medicine Technology:Trading Halted Today in Questcor Pharmaceuticals Common Stock 2ViaCyte, Inc., Receives Three Additional U.S. Patents, Supporting its Development of a Stem Cell Derived Treatment for Diabetes 2
(Date:9/15/2014)... Today, Zane Benefits, the #1 Online Health Benefits Solution, ... show. , According to Zane Benefits, health insurance ... make sense to choose a “one size fits all” ... employee as much as 60 percent on health insurance ... on Business , Chris Redgrave, highlights the rising costs ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 The ... & World Report consists of seven hospitals using OnBase ... Hopkins Hospital and Cleveland Clinic were ranked at the ... spots respectively. The rankings cover nearly 5,000 medical centers ... of 17 hospitals that scored highest in at least ...
(Date:9/15/2014)... (HealthDay News) -- U.S. heart experts recommend doctors use ... evaluating young people for underlying heart disease that could ... Association and the American College of Cardiology said in ... family medical history along with a physical examination can ... from birth) risks for sudden cardiac death. ...
(Date:9/15/2014)... DALLAS, TX September 12, 2014 - An estimated ... disorder (PTSD) at some point during their lifetime. Brought ... PTSD is the result of altered chemistry and physiology ... a normal brain versus one altered by PTSD is ... from the Center for BrainHealth at The University of ...
(Date:9/15/2014)... Palo Alto, CA (PRWEB) September 15, 2014 ... seventh anniversary since its founding in 2007. To mark ... the local community for supporting the village and helping ... Village provides a safe, secure and fun community for ... connected to the community and live in their own ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2Health News:Seven of Top Ten Hospitals in the U.S. Leverage OnBase by Hyland ECM Solution 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:EEG study findings reveal how fear is processed in the brain 2Health News:Avenidas Village Celebrates Anniversary 2
... Due to New PhRMA Marketing Regulations and Converging ... are taking on the 2009 PhRMA code with ... company whose integrated engagement solutions have been generating ... past two years the company has helped brands ...
... /PRNewswire/ -- Akerman Senterfitt, one of the ... top 100 firms in the U.S., today announced that ... the auspices of the American Health Lawyers Association (AHLA) ... and issues concerning privilege and confidentiality. The live audiocast ...
... SGP ) is scheduled to announce its sales ... year on Tuesday, Feb. 3, 2009. At 8 a.m. ... to review results for the 2008 fourth quarter and full ... members of management will host the conference call. To listen ...
... 6 Elsevier, the world,s,leading publisher of ... announced today that fifty prestigious titles from ... on ScienceDirect, its online,scientific research platform. , ... Spanish language medical publisher acquired by,Elsevier in ...
... these cold, snowy monthsROSEMONT, Ill., Jan. 6 ... inside with a blanket and a good book -- ... whole new excitement of sports and outdoor activities for ... ( http://orthoinfo.aaos.org/topic.cfm?topic=A00321 ), snowboarding and other cold-weather activities are ...
... North America of,Charlotte, NC, announces the completion of ... provider of support services operating,mainly in the business ... wholly owned subsidiary of Compass Group North America ... America focused on delivering,support services to the business ...
Cached Medicine News:Health News:Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines 2Health News:Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines 3Health News:Akerman Senterfitt Hosts National Panel Discussion on Patient Safety Organizations 2Health News:Akerman Senterfitt Hosts National Panel Discussion on Patient Safety Organizations 3Health News:Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings 2Health News:Elsevier to Include Doyma Spanish Medical Collection Titles on ScienceDirect 2Health News:Elsevier to Include Doyma Spanish Medical Collection Titles on ScienceDirect 3Health News:Skate Through Winter Sports Injury-Free 2Health News:Skate Through Winter Sports Injury-Free 3Health News:Compass Group North America Acquires KIMCO Corporation 2
The Marco E-Z Tilt Chair combines the most simplified manual reclining motion with a new modern, sophisticated appearance....
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
Medicine Products: